Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Airtree
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
HaastSeries A $12M · 5 mo ago • 51-200 employees • 8 roles
We help organisations manage digital risk, enabling them to find and resolve brand and legal compliance issues, across their entire…
Process24 roles
Process Street is the Compliance Operations Platform that turns your policies into automated, AI-enforced workflows. Prove every step, pass…
Get answers from your data 1000x faster and turn them into revenue-driving audiences, actions, and workflows.
The mission of Thomson Instrument Company is to partner with our customers, provide technical expertise and deliver practical scientific…
CodeSceneVenture round $8.1M · 3 yr ago • Founded 2016
CodeScene analyses code health and developer behaviour to prioritise technical debt. Its behavioural code analysis links quality to…
BreadwinnerConvertible Note $35k · 3 yr ago • Founded 2021 • 1 role
Native Salesforce apps connecting NetSuite, QuickBooks, Xero, and Stripe to Salesforce with real-time, two-way sync. On the AppExchange…

Overview

Kimia was built to make technical expertise accessible across the entire organisation. Today, Kimia turns chemical knowledge into instant, revenue-driving intelligence for suppliers and distributors around the world.

News

Press release The Manila Times 1 year ago
Kimia Therapeutics Appoints Imran S. Haque, Ph.D. as Chief Technology Officer
BERKELEY, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced the appointment of Imran S. Haque, Ph.D., to the role of chief technolog
Read more
Report
News YahooFinance 3 years ago
Kimia Therapeutics Raises $55 Million Series A
- Fundraise led by The Column Group and Dimension - - Kimia is advancing its ATLAS platform that combines high-throughput chemistry with chemical biology, genome editing and machine learning to create a chemical map of the druggable proteome and accelerat
Read more
Report